8. Integrative medicine used for the treatment of viral myopericarditis: A case presentation of an immunocompetent 22 year-old male with stress-induced reactivation of epstein barr virus (EBV) with cardiac involvement
Autor: | H.O. Ventura, M.L. Lara-Marquez |
---|---|
Rok vydání: | 2013 |
Předmět: |
Pathology
medicine.medical_specialty Aspirin Troponin T Endocrine and Autonomic Systems business.industry Immunology Tonsillitis medicine.disease_cause Chest pain medicine.disease Epstein–Barr virus Gastroenterology Behavioral Neuroscience Internal medicine Troponin I medicine Lymph medicine.symptom business Myopericarditis medicine.drug |
Zdroj: | Brain, Behavior, and Immunity. 32:e3 |
ISSN: | 0889-1591 |
DOI: | 10.1016/j.bbi.2013.07.020 |
Popis: | There is a paucity of literature in EBV-Myopericarditis. Conventional treatment is based in Non-steroidal anti-inflammatory that aggravate myocardial injury. We present a Myopericarditis in a 22-year-old immunocompetent male by a stress-induced reactivation of EBV diagnosed by PCR in peripheral-blood. After three days of high fever, tonsillitis, enlarged submaxilar lymph nodes, and general myalgias, is admitted to the hospital with 1 h onset of severe retrosternal pleuritic pain, that evolved to a Myopericarditis with rapid increase of chest oppressive pain, in the precordial area, with diaphoresis, EKG abnormalities (diffuse ST-segment changes with elevation in AVL, V2–V6 derivations and PR depression) and within 8-h increased cardiac enzymes, Troponin T (0.893 ng/ml) Troponin I (18 ng/ml), CK-MB (82.02 ng/ml). Since evidence of myocardial injury increased, treatment was changed during the second severe chest pain, to Classic Homeopathy, treating the patient with Arnica montana (extract that contains Sesquiterpene lactones that inhibit NF-kappa B) for five weeks tapering the dose to then be followed by Thuja officinalis for 1 week. Concomitantly, Aspirin (1 g/d) for 4 weeks was added. After this integrative medicine treatment, there was a significant clinical improvement, fever subsided, C-Reactive-Protein decreased from 11.5 to 0.68 mg/dl, all the cardiac enzymes and EKG normalized rapidly. Additional results will be discussed. We present a novel therapeutic approach to a potentially fatal disease providing a starting point for groundbreaking research. |
Databáze: | OpenAIRE |
Externí odkaz: |